Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis in Hispanics: a study of clinical disease expression.
[Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)].
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
IL-17 and Th17 Cells.
Demyelination of the hippocampus is prominent in the cuprizone model.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Teriflunomide modest help but safe for MS
GlaxoSmithKline Protocol Summaries: Firategrast
Clinically isolated syndrome - Rethinking the diagnosis.
Management of worsening multiple sclerosis with mitoxantrone: a review.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.
Experimental models of spontaneous autoimmune disease in the central nervous system.
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
Sex differences in autoimmune disease.
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?

Pages